Assignee
THRYV THERAPEUTICS INC
CA·0 granted patents·2 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
2 records- 0156US2024309005A1Pyrazolo[3,4-d]pyrimidin-6-yl-sulfonamide derivatives for the inhibition of sgk-1THRYV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0240US2025320215A1Salts of n-[4-(4-[[2-(dimethylamino)ethyl]amino]-3-methyl-1h-pyrazolo[3,4-d]pyrimidin-6-yl)-2-fluorophenyl]-2,5-difluorobenzenesulfonamide and crystalline forms thereofTHRYV THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THRYV THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →